SFM Stock Analysis: Sprouts Farmers Market | NASDAQ
Grocery Stores | NASDAQ, USA | Market Cap: 6.028m USD | 12M Return: -36% | US85208M1027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 148M
EPS Trend: 96.9%
Qual. Beats: 0
Rev. Trend: 99.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sprouts Farmers Market, Inc. is a U.S. specialty grocer that operates healthy grocery stores focused on fresh, natural, and organic food products. The company sells both perishable categories-such as produce, meat and meat alternatives, seafood, deli, bakery, floral, and dairy alternatives-and non-perishable categories, including grocery items, vitamins and supplements, bulk foods, frozen items, beer and wine, and natural health and body care. All products are sold under the Sprouts brand.
The company operates within the Consumer Staples sector, specifically the Food Retail sub-industry, where it competes in the natural and organic specialty grocery segment alongside chains such as Whole Foods Market and Natural Grocers, as well as conventional supermarkets that have expanded their organic offerings. Sprouts business model emphasizes a smaller-footprint, value-oriented specialty format that targets health-conscious shoppers seeking lifestyle-friendly ingredients like organic, plant-based, keto, paleo, non-GMO, and gluten-free options.
Sprouts was founded in 1943 and is headquartered in Phoenix, Arizona. The company trades on the NASDAQ under the ticker symbol SFM and went public on August 1, 2013, with a current mid-cap market capitalization.
- Comp sales growth drives sustained revenue outperformance
- New store openings accelerate double-digit unit expansion
- Competition from Aldi and Trader Joes pressures market share
| Net Income: 502.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -5.08 > 1.0 |
| NWC/Revenue: -0.07% < 20% (prev -0.14%; Δ 0.07% < -1%) |
| CFO/TA 0.16 > 3% & CFO 673.0m > Net Income 502.9m |
| Net Debt (1.88b) to EBITDA (1.00b): 1.88 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (94.4m) vs 12m ago -4.42% < -2% |
| Gross Margin: 37.37% > 18% (prev 38.08%; Δ -0.71% > 0.5%) |
| Asset Turnover: 221.9% > 50% (prev 222.0%; Δ -0.09% > 0%) |
| Interest Coverage Ratio: 311.5 > 6 (EBIT TTM 673.8m / Interest Expense TTM 2.16m) |
| A: -0.00 (Total Current Assets 770.8m - Total Current Liabilities 777.3m) / Total Assets 4.33b |
| B: 0.15 (Retained Earnings 642.2m / Total Assets 4.33b) |
| C: 0.17 (EBIT TTM 673.8m / Avg Total Assets 4.06b) |
| D: 0.53 (Book Value of Equity 1.50b / Total Liabilities 2.83b) |
| Altman-Z'' = 2.15 = BBB |
| DSRI: 0.99 (Receivables 65.5m/61.5m, Revenue 9.00b/8.40b) |
| GMI: 1.02 (GM 38.08% / 37.37%) |
| AQI: 0.88 (AQ_t 0.14 / AQ_t-1 0.16) |
| SGI: 1.07 (Revenue 9.00b / 8.40b) |
| TATA: -0.04 (NI 502.9m - CFO 673.0m) / TA 4.33b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of October 07, 2026, the stock is trading at USD 65.17 with a total of 2,534,171 shares traded. Over the past week, the price has changed by +0.80%, over one month by -14.37%, over three months by -24.72% and over the past year by -35.96%.
Current recommended Stop Loss: 61.70 (which is 5.3% or 1.2 ATR below the current price).
Sprouts Farmers Market has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold SFM.
- StrongBuy: 4
- Buy: 1
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 94.5 | 45% |
P/E Trailing = 12.1295
P/E Forward = 11.1235
P/S = 0.6695
P/B = 4.1036
P/EG = 1.3911
Revenue TTM = 9.00b USD
EBIT TTM = 673.8m USD
EBITDA TTM = 1.00b USD
Long Term Debt = 1.92b USD (estimated: total debt 2.11b - short term 182.3m)
Short Term Debt = 182.3m USD (from shortTermDebt, last quarter)
Debt = 2.11b USD (from shortLongTermDebtTotal, last quarter) (leases 2.11b already included)
Net Debt = 1.88b USD (calculated: Debt 2.11b - CCE 223.9m)
Enterprise Value = 7.91b USD (6.03b + Debt 2.11b - CCE 223.9m)
Interest Coverage Ratio = 311.5 (Ebit TTM 673.8m / Interest Expense TTM 2.16m)
EV/FCF = 22.27x (Enterprise Value 7.91b / FCF TTM 355.2m)
FCF Yield = 4.49% (FCF TTM 355.2m / Enterprise Value 7.91b)
FCF Margin = 3.94% (FCF TTM 355.2m / Revenue TTM 9.00b)
Net Margin = 5.58% (Net Income TTM 502.9m / Revenue TTM 9.00b)
Gross Margin = 37.37% ((Revenue TTM 9.00b - Cost of Revenue TTM 5.64b) / Revenue TTM)
Gross Margin QoQ = 38.72% (prev 37.58%)
Tobins Q-Ratio = 1.83 (Enterprise Value 7.91b / Total Assets 4.33b)
Interest Expense / Debt = 0.10% (Interest Expense 2.16m / Debt 2.11b)
Taxrate = 25.09% (168.4m / 671.3m)
NOPAT = 504.8m (EBIT 673.8m * (1 - 25.09%))
Current Ratio = 0.99 (Total Current Assets 770.8m / Total Current Liabilities 777.3m)
Debt / Equity = 1.40 (Debt 2.11b / totalStockholderEquity, last quarter 1.50b)
Debt / EBITDA = 1.88 (Net Debt 1.88b / EBITDA 1.00b)
Debt / FCF = 5.30 (Net Debt 1.88b / FCF TTM 355.2m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.39% (Net Income 502.9m / Total Assets 4.33b)
RoE = 34.84% (Net Income TTM 502.9m / Total Stockholder Equity 1.44b)
RoCE = 20.01% (EBIT 673.8m / Capital Employed (Equity 1.44b + L.T.Debt 1.92b))
RoIC = 14.37% (NOPAT 504.8m / Invested Capital 3.51b)
WACC = 5.19% (E(6.03b)/V(8.13b) * Re(6.98%) + D(2.11b)/V(8.13b) * Rd(0.10%) * (1-Tc(0.25)))
Discount Rate = 6.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.97 | Cagr: -3.39%
[DCF] Terminal Value 73.10% ; FCFF base≈414.1m ; Y1≈363.1m ; Y5≈293.4m
[DCF] Fair Price = 30.32 (EV 4.71b - Net Debt 1.88b = Equity 2.83b / Shares 93.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.89 | EPS CAGR: 32.71% | SUE: 0.26 | # QB: 0
Revenue Correlation: 98.98 | Revenue CAGR: 12.72% | SUE: 0.12 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.23 | Chg30d=-0.39% | Revisions=-62% | Analysts=12
EPS current Year (2026-12-31): EPS=5.54 | Chg30d=-0.11% | Revisions=-46% | GrowthEPS=+4.4% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=5.92 | Chg30d=-0.56% | Revisions=+0% | GrowthEPS=+6.7% | GrowthRev=+7.6%
[Analyst] Revisions Ratio: -48% (up=6, down=20)